# Vitalant – FDA Inspection, Nov 22, 2024

Source: https://www.keypedia.com/records/fda_inspections/vitalant/ef531390-28ec-4538-840b-31ea72884326
Source feed: FDA_Inspections

> FDA inspection 1258010 of Vitalant, November 22, 2024. Classification: No Action Indicated (NAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1258010
- Company Name: Vitalant
- Inspection Date: 2024-11-22
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1106275 - 2019-09-05
- [FDA Inspection 1000905 - 2017-02-10](https://www.keypedia.com/records/fda_inspections/vitalant/16457b79-8da2-405e-8b06-7a324482a026)
- FDA Inspection 937619 - 2015-07-29
- [FDA Inspection 848182 - 2013-09-13](https://www.keypedia.com/records/fda_inspections/vitalant/5be7f3d8-d2f0-469e-bae3-e9abd3f4563d)
- [FDA Inspection 795373 - 2012-08-15](https://www.keypedia.com/records/fda_inspections/vitalant/4e0d2829-72dc-49b1-8fcf-12d2ff488c7f)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/kaarin-m-slotte/2960bbe1-17ba-4295-9aa8-2514a1595336)

Company: https://www.keypedia.com/companies/vitalant/7a5079bf-12d6-460a-b20d-eacf8b0f3f11

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d